Covance

Covance Finalizes Merck Deal, Delays Construction of Preclinical Unit

Thursday, August 20, 2009 06:35 AM

Covance officially closed a deal with Merck earlier this week to provide genomics analysis services to the drug developer for the next five years. Under the terms of the $145-million agreement, the contract research organization (CRO) acquired Merck’s Seattle-based Gene Expression Laboratory. All Merck employees related to the Seattle facility became Covance employees as of August 17.

More... »

Covance, MDS Pharma Earn MHRA Accreditation

Thursday, August 13, 2009 08:21 AM

Covance and MDS Pharma Services both recently earned standard and supplementary accreditation for the conduct of clinical pharmacology in Europe by the Medicines and Healthcare products Regulatory Agency (MHRA).

More... »

Covance Ups Guidance as Early- and Late-Stage Revenues Improve in Q2

Wednesday, July 29, 2009 08:36 PM

Covance reported an increase in both early- and late-stage drug development revenues for the second quarter of 2009 compared with the first quarter, but early-stage revenues remain significantly lower than the same period last year.

More... »

Phase Forward Agrees to $10M Acquisition, Multi-Year Partnership with Covance

Wednesday, July 15, 2009 01:30 PM

Covance is selling its interactive voice and web response services (IVR/IWR) business to eClinical provider Phase Forward for $10 million cash, and the two companies have entered into a multi-year agreement making Phase Forward a preferred provider for the contract research organization (CRO).

More... »

CROs See Brighter Future Despite Cancellations

Monday, May 4, 2009 08:00 AM

Contract research organizations (CROs) continue to feel the adverse effects of cancellations and negative foreign exchange, but their most recent earnings reports show some promise.

More... »

Covance's Q1 Profit Drops, Cuts 2009 Forecast

Thursday, April 30, 2009 07:10 AM

Covance's first quarter profit fell 18%, and the company reduced its 2009 profit guidance. In after hours trading, Covance's shares fell 8.2% to $37.

More... »

Covance Expands in Latin America

Tuesday, April 14, 2009 07:48 AM

Covance opened new clinical development offices in Santiago, Chile, and Lima, Peru, and expanded its office in Buenos Aires, Argentina, increasing the contract research organization (CRO)’s presence in Latin America.

More... »

Covance Acquires Swiss Pharma Contract

Tuesday, March 24, 2009 07:43 AM

Covance has expanded its clinical pharmacology presence in Europe with the recent acquisition of Swiss Pharma Contract, a contract research organization (CRO) in Basel, Switzerland, for an undisclosed sum.

More... »

Covance Expands Presence in Ukraine, Slovakia and Israel

Wednesday, February 4, 2009 10:00 AM

Covance opened three new clinical development offices in Central and Eastern Europe and the Middle East to speed clinical trials and develop strategic relationships in those areas.

More... »

Covance Revenues Up, Maintains Guidance

Thursday, January 29, 2009 04:21 PM

Covance released strong fourth quarter and year end 2008 financial results late Wednesday with revenue increases in both early and late-stage development segments.

More... »